The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
The Non-Malignant Channel is supported with funding from Agios (Gold).
The Thalassemia Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCAT 2024 | Preventing the progressive decline in bone mineral density observed in thalassemia
Julian Waung, BM, PhD, Whittington Hospital, London, UK, discusses the importance of achieving a high peak bone mass and highlights strategies to slow bone decline in individuals with thalassemia. Dr Waung introduces the acronym “SAVING THE BONES” to address risk factors regulating bone health, including smoking, alcohol, vitamin D, medications, and more. This interview took place at the 19th Annual Scientific Conference of the Academy for Sickle Cell and Thalassaemia (ASCAT 2024) in London, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
